Annexon Sets Sights on Phase III Geographic Atrophy Trial Despite Missing Mid-Stage Mark 5/25/2023

Braeburn’s Long-Acting Brixadi Receives FDA Clearance to Treat Opioid Use Disorder 5/25/2023

What People with Autism Wish Their Employers Knew 5/25/2023

Taking a daily multivitamin supplement can slow age-related memory decline, finds a large study led by researchers at Columbia University and Brigham and Women's Hospital/Harvard.

"Cognitive aging is a top health concern for older adults, and this study suggests that there may be a simple, inexpensive way to help older adults slow down memory decline,"

Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits 5/24/2023

Moving From the Bench to Management: How to Become an Effective Leader 5/24/2023

Takeda Cuts Jobs in California Following Massachusetts Layoffs (Updated) 5/24/2023

Scientists at St. Jude Children’s Research Hospital and the University of Texas Southwestern Medical Center studied the structure and function of a transporter involved in cancer and immunity. They captured six structures of the transporter, including when it was bound to an inhibitor, providing unprecedented insight into how it works. The findings, published in Cell, have implications for drug development.

FDA Approves First Nasal Nalmefene Spray for Opioid Overdose 5/23/2023

Roche Terminates Second Phase II Schizophrenia Trial 5/23/2023

ReNAgade Launches with $300M to More Easily Deliver RNA Medicines 5/23/2023

Ironwood to Pay $1B to Acquire VectivBio, Late-Stage Digestive Therapy 5/23/2023

Billy Dunn’s Prothena Board Position Reignites Ethical Debate 5/23/2023

Blueprint Adds Indolent Systemic Mastocytosis to Ayvakit’s Label 5/23/2023

10 Pharma Tech Jobs Available Now 5/23/2023

Insilico Medicine (Insilico), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that the company has nominated a potentially best-in-class preclinical candidate targeting ENPP1 for cancer immunotherapy and the potential treatment of Hypophosphatasia (HPP).

ENPP1 is an ecto-nucleotide pyrophosphatase that plays an important role in purinergic signaling that regulates immune, cardiovascular, neurological, and hematological system functions.

AbbVie, Genmab Score FDA Nod for DLBCL as Blood Cancer Space Heats Up 5/22/2023

Phase III Results Prime Dupixent as First Potential Biologic Approval for COPD 5/22/2023

Phase III Results Prime Dupixent as First Potential Biologic Approval for COPD 5/22/2023

Krystal Gets First FDA Approval for Redosable Gene Therapy, Rare Skin Disease 5/22/2023